Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2015

“Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2015

Summary

GlobalData’s clinical trial report, “Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2015″” provides an overview of Vernal Keratoconjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vernal Keratoconjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.”

“Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vernal Keratoconjunctivitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Vernal Keratoconjunctivitis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Astellas Pharma Inc. 28
Clinical Trial Overview of Astellas Pharma Inc. 28
Senju Pharmaceutical Co., Ltd. 29
Clinical Trial Overview of Senju Pharmaceutical Co., Ltd. 29
Santen S.A.S. (Inactive) 30
Clinical Trial Overview of Santen S.A.S. (Inactive) 30
Santen Pharmaceutical Co., Ltd. 31
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Novagali Pharma SA 33
Clinical Trial Overview of Novagali Pharma SA 33
Laboratoires Thea S.A. 34
Clinical Trial Overview of Laboratoires Thea S.A. 34
Funds for Research in Ophthalmology 35
Clinical Trial Overview of Funds for Research in Ophthalmology 35
Chiltern International Limited 36
Clinical Trial Overview of Chiltern International Limited 36
Ajanta Pharma Limited 37
Clinical Trial Overview of Ajanta Pharma Limited 37
Clinical Trial Overview of Top Institutes / Government 38
Campus Bio-Medico University Rome 38
Clinical Trial Overview of Campus Bio-Medico University Rome 38
Azienda Ospedaliero-Universitaria Meyer 39
Clinical Trial Overview of Azienda Ospedaliero-Universitaria Meyer 39
Faculty of Medicine Siriraj Hospital, Mahidol University 40
Clinical Trial Overview of Faculty of Medicine Siriraj Hospital, Mahidol University 40
Ghent University Hospital 41
Clinical Trial Overview of Ghent University Hospital 41
Kyoto Prefectural University of Medicine 42
Clinical Trial Overview of Kyoto Prefectural University of Medicine 42
Five Key Clinical Profiles 43
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72″
“List of Tables
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Vernal Keratoconjunctivitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 28
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Senju Pharmaceutical Co., Ltd., 2015* 29
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen S.A.S. (Inactive), 2015* 30
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 31
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 32
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novagali Pharma SA, 2015* 33
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 34
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Funds for Research in Ophthalmology, 2015* 35
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Limited, 2015* 36
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2015* 37
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Campus Bio-Medico University Rome, 2015* 38
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero-Universitaria Meyer, 2015* 39
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Medicine Siriraj Hospital, Mahidol University, 2015* 40
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 41
Vernal Keratoconjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 42″
“List of Figures
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Vernal Keratoconjunctivitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Vernal Keratoconjunctivitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Vernal Keratoconjunctivitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Vernal Keratoconjunctivitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Vernal Keratoconjunctivitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Vernal Keratoconjunctivitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 70″